JP2003250517A - Substrate for cell culture and method for cell culture - Google Patents

Substrate for cell culture and method for cell culture

Info

Publication number
JP2003250517A
JP2003250517A JP2002055510A JP2002055510A JP2003250517A JP 2003250517 A JP2003250517 A JP 2003250517A JP 2002055510 A JP2002055510 A JP 2002055510A JP 2002055510 A JP2002055510 A JP 2002055510A JP 2003250517 A JP2003250517 A JP 2003250517A
Authority
JP
Japan
Prior art keywords
cells
substrate
cell
cell culture
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002055510A
Other languages
Japanese (ja)
Inventor
Naohiko Yoshida
尚彦 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shinano Kenshi Co Ltd
Original Assignee
Shinano Kenshi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinano Kenshi Co Ltd filed Critical Shinano Kenshi Co Ltd
Priority to JP2002055510A priority Critical patent/JP2003250517A/en
Publication of JP2003250517A publication Critical patent/JP2003250517A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a substrate for cell culture capable of carrying out three- dimensional coculture of cells in a state laminated in the thickness direction of the substrate in order to maximize effects of intercellular contact, and a method for cell culture. <P>SOLUTION: The substrate 10 for the cell culture is composed of a cell nonadhesive material without making the cell to be cultured adhere. The substrate 10 has slitlike through-holes 12 for culturing the different cells in the laminated state in the thickness direction of the substrate 10 in the interior thereof. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は細胞培養用基板およ
び細胞培養方法に関する。
TECHNICAL FIELD The present invention relates to a cell culture substrate and a cell culture method.

【0002】[0002]

【従来技術】新薬開発の際、動物実験による毒性試験等
を行って、毒性の少ない薬品のスクリーニングをする
が、その際極めて多数の動物(マウス)を死なせること
になる。また、これら動物が非常に高価であることか
ら、創薬早期における毒性評価のための動物実験にかか
る費用は数千億円と見積もられ、莫大なコストがかかる
要因となっている。そのため、動物に代わり得るものと
して、近年、生体外で細胞を培養、生育させた培養細胞
が開発されつつあり、これを用いて薬剤の生理活性や毒
性を試験することが行われている。例えば、代替法とし
て、培養皮膚細胞など、一部の細胞培養を動物実験代替
物として利用する動きがでてきているが、体内において
薬物を代謝する役目をもっている細胞でテストすること
が重要であることから、完全な代替物としての能力を有
するには至っていない。
2. Description of the Related Art When developing a new drug, a toxicity test is conducted by an animal experiment to screen a drug having a low toxicity, but an extremely large number of animals (mouse) are killed. Further, since these animals are very expensive, it is estimated that the cost for the animal experiment for the toxicity evaluation at the early stage of drug discovery is several hundred billion yen, which is a factor of enormous cost. Therefore, in recent years, as a substitute for animals, cultured cells in which cells are cultured and grown in vitro are being developed, and the physiological activity and toxicity of drugs are tested using these. For example, as an alternative method, some cell cultures such as cultured skin cells are being used as alternatives to animal experiments, but it is important to test with cells that have the role of metabolizing drugs in the body. Therefore, it has not reached the level of a perfect substitute.

【0003】上記の現状を踏まえ、生体内で薬物の代謝
を行う肝臓の細胞を体外で培養し、生体内で存在したと
きと同等の能力を発現させることができれば、動物実験
の犠牲となる実験動物の数を大幅に減らし得る動物実験
代替物となりうる。上記実現のためには、肝臓の細胞、
特に代謝薬物の機能を直接的に担う肝実質細胞を良好な
状態で体外培養することが重要である。生体内では、複
数種の細胞が3次元的な配列で接触して存在することが
多い。従来、細胞が接着しにくい物質や、逆に接着しや
すい物質を基板に塗布し、複数種の細胞を播種して、細
胞を2次元的に配列させることが知られている。
Based on the above situation, if liver cells that metabolize drugs in vivo are cultivated in vitro and the same ability as when they exist in vivo can be expressed, they will be sacrificed in animal experiments. It can be an alternative to animal experiments that can significantly reduce the number of animals. To achieve the above, liver cells,
In particular, it is important to in vitro culture hepatic parenchymal cells, which are directly responsible for the function of metabolic drugs, in good condition. In a living body, a plurality of types of cells are often present in contact with each other in a three-dimensional array. Conventionally, it is known that a substance to which cells are difficult to adhere or a substance to which cells are easily adhered is applied to a substrate, and a plurality of types of cells are seeded to arrange the cells two-dimensionally.

【0004】[0004]

【発明が解決しようとする課題】このような細胞接着部
位の制限は、しばしば共培養を行うための手法として用
いられる。しかし、2次元の共培養系では、異種細胞間
接触が異種細胞同士の境界のみに限られ、細胞間接触の
効果を十分に活かすことができないという課題がある。
Such restriction of cell adhesion sites is often used as a method for co-culturing. However, in the two-dimensional co-culture system, the contact between different kinds of cells is limited only to the boundary between different kinds of cells, and the effect of the contact between cells cannot be fully utilized.

【0005】そこで、本発明では、細胞間接触の効果を
最大にするために、細胞を基板の厚み方向に積層した状
態の3次元共培養が可能な細胞培養用基板および細胞培
養方法を提供する。
Therefore, the present invention provides a substrate for cell culture and a cell culture method capable of three-dimensional co-culturing in which cells are stacked in the thickness direction of the substrate in order to maximize the effect of cell-cell contact. .

【0006】[0006]

【課題を解決するための手段】すなわち、本発明に係る
細胞培養用基板は、培養すべき細胞が接着しない、非細
胞接着性の材料からなる細胞培養用基板であって、内部
で、異なる細胞が基板の厚み方向に積層状態で培養され
るスリット状の貫通孔を有することを特徴としている。
非接着性の材料にシリコンゴムもしくはアガロースゲル
を用いることができる。シリコンゴムには細胞が接着し
ない。アガロースは、多糖類であり、水酸基を有してい
て親水性をもつが、親水性が強すぎて細胞が接着しない
と考えられる。このアガロースゲルを用いる場合、アガ
ロース含量が6wt%以上であると好適である。アガロ
ース含量が6wt%以上であると、アガロースゲルが保
形性を有するので、成形型を用いて必要な形状に容易に
成形することができるのである。なお、非接着性材料は
シリコンゴムやアガロースゲルに限定されることはな
い。
[Means for Solving the Problems] That is, the cell culture substrate according to the present invention is a cell culture substrate made of a non-cell adhesive material to which cells to be cultivated do not adhere, and different cells are internally formed. Has a slit-shaped through hole that is cultured in a laminated state in the thickness direction of the substrate.
Silicone rubber or agarose gel can be used as the non-adhesive material. Cells do not adhere to silicone rubber. Agarose is a polysaccharide and has a hydroxyl group and has hydrophilicity, but it is considered that cells are not adhered because the hydrophilicity is too strong. When using this agarose gel, the agarose content is preferably 6 wt% or more. When the agarose content is 6 wt% or more, the agarose gel has a shape-retaining property, so that it can be easily molded into a required shape using a molding die. The non-adhesive material is not limited to silicone rubber or agarose gel.

【0007】また本発明に係る細胞培養用装置は、上記
細胞培養用基板を、細胞接着性の材料からなる培養皿上
に密着させたことを特徴とする。また、本発明に係る細
胞培養方法では、この細胞培養用装置に培養液を供給
し、前記基板上に多数の第1の細胞を播種し、所要温度
条件に維持して、播種された細胞を前記貫通孔内で前記
培養皿に接着した状態で培養する工程と、前記貫通孔内
で培養された第1の細胞上に第2の細胞を培養する工程
とを具備することを特徴とする。
The cell culture device according to the present invention is characterized in that the cell culture substrate is brought into close contact with a culture dish made of a cell adhesive material. Further, in the cell culture method according to the present invention, a culture solution is supplied to the cell culture device, a large number of first cells are seeded on the substrate, and the seeded cells are maintained at a required temperature condition. It is characterized by comprising a step of culturing in a state of being adhered to the culture dish in the through hole, and a step of culturing a second cell on the first cell cultured in the through hole.

【0008】[0008]

【実施の形態】図1は細胞培養用基板10を示す。基板
10は、シリコンゴム製であり、厚さが約1mmの円板
状をなす。この基板10に、スリット状の貫通孔12を
平行に形成した。貫通孔12の幅は0.5mmに設定し
た。肝実質細胞の大きさは約50μmであるから、細胞
は貫通孔12内に10個程度並ぶ。なお、貫通孔12の
長さ、幅は特に限定されるものではない。
DESCRIPTION OF THE PREFERRED EMBODIMENTS FIG. 1 shows a cell culture substrate 10. The substrate 10 is made of silicon rubber and has a disk shape with a thickness of about 1 mm. In this substrate 10, slit-shaped through holes 12 were formed in parallel. The width of the through hole 12 was set to 0.5 mm. Since the size of liver parenchymal cells is about 50 μm, about 10 cells are arranged in the through holes 12. The length and width of the through hole 12 are not particularly limited.

【0009】貫通孔12はレーザー加工等によって形成
することができる。基板10はシリコンゴム製に限られ
ることはなく、アガロースゲルなど、細胞が接着しない
材料のものを使用できる。前記のように、アガロース含
量が6wt%以上であると、アガロースゲルが保形性を
有するので、成形型を用いて必要な形状に容易に成形す
ることができるのである。
The through hole 12 can be formed by laser processing or the like. The substrate 10 is not limited to the one made of silicon rubber, and may be made of a material such as agarose gel that does not adhere to cells. As described above, when the agarose content is 6 wt% or more, the agarose gel has a shape-retaining property, and thus the agarose gel can be easily molded into a required shape using a molding die.

【0010】細胞培養の際には、図2に示すように、基
板10を細胞接着性を有する、TC12ウエル(well)
等の培養皿14上に密着させて細胞培養用装置とする。
基板10を培養皿14の表面上に押圧することで基板1
0が培養皿14に密着し、細胞が基板10と培養皿14
との間に進入することはない。
When culturing cells, as shown in FIG. 2, the substrate 10 is provided with TC12 wells having cell adhesiveness.
The cell culture device 14 is brought into close contact with the culture dish 14 to prepare a cell culture device.
By pressing the substrate 10 onto the surface of the culture dish 14, the substrate 1
0 adheres to the culture dish 14, and the cells are placed on the substrate 10 and the culture dish 14.
There is no entry between and.

【0011】培養皿14に基板10が浸る程度に培養液
を供給し、培養液中に第1の細胞を播種する。第1の細
胞は、スリット状の貫通孔12内に次第に沈降し、培養
皿14に接着した状態で増殖する。細胞は、貫通孔12
内で単層状態で広がる。次いで、培養液に第2の細胞を
播種する。第2の細胞も貫通孔12内に沈降、伸展し、
第1の細胞を足場として増殖する。第2の細胞も単層状
態で培養される。
The culture solution is supplied to the extent that the substrate 10 is immersed in the culture dish 14, and the first cells are seeded in the culture solution. The first cells gradually settle in the slit-shaped through holes 12 and grow in a state of being adhered to the culture dish 14. The cell has a through hole 12
It spreads in a single layer inside. Then, the second cell is seeded in the culture medium. The second cells also settle and spread in the through holes 12,
Propagate using the first cell as a scaffold. The second cell is also cultured in a monolayer state.

【0012】図3は、培養が完了した後の状態を示す模
式図である。層状をなす第1の細胞16と第2の細胞1
8とが層間接触する3次元的構造をなすことから、生体
内とほぼ同等の細胞配列が期待でき、生体外での培養に
もかかわらず、生体内で発現していた機能を発揮でき、
肝毒性値評価チップなどとして好適に用いることができ
る。
FIG. 3 is a schematic diagram showing a state after the culture is completed. Layered first cell 16 and second cell 1
Since it has a three-dimensional structure in which 8 and layers are in contact with each other, a cell array almost equivalent to that in vivo can be expected, and the function expressed in vivo can be exhibited despite the culture in vitro.
It can be suitably used as a hepatotoxicity evaluation chip or the like.

【0013】なお、培養液や、培養、生育条件は特に限
定されず、通常の培養液、条件で行うことができる。ま
た、単独培養ではなく、例えば肝細胞と他の細胞と共培
養して、肝細胞機能を高安定化させ、生体組織に近い培
養肝細胞を得ることもできる。肝細胞以外にも、細胞同
士が接着するタイプの細胞、例えば、筋肉細胞、神経細
胞、血管内皮細胞、内分泌系細胞、皮膚/粘膜細胞など
の細胞の培養も行うことができる。
The culture medium and the culture and growth conditions are not particularly limited, and the usual culture medium and conditions can be used. Alternatively, instead of singly culturing, for example, hepatocytes and other cells may be co-cultured to highly stabilize the function of hepatocytes and to obtain hepatocytes in culture close to biological tissues. In addition to hepatocytes, cells of a type in which cells adhere to each other, for example, muscle cells, nerve cells, vascular endothelial cells, endocrine cells, skin / mucosal cells and the like can be cultured.

【0014】[0014]

【実施例】図2に示す細胞培養用装置を用いた。この細
胞培養用装置に、PSN(Penicillin、Streptomycin、
Neomycin:いずれも抗生物質)が含有されたWE培地
(Williams´Medium E)90vol%に10vol%のFB
S(Fetal bovine serum:牛胎児血清)を添加した培
地(培養液)を、基板10が浸る程度の量供給し、マウ
スより単離した肝実質細胞を培地に懸濁した(播種し
た)。さらに、EGF10ng/ml(Epidermal growth
factor:表皮増殖因子)、インスリン(insulin)1μ
g/mlを加え、肝実質細胞の増殖を促した。細胞は、1
ウエル(well)あたり1mlの培地を用い、15万セル
(cell)ずつ播種した。播種後、定期的に培地、および
細胞内のRNAを回収し、アルブミン産生能と、シトク
ロムP450のmRNA発現を測定した。図4にアルブミン
産生能を示す。図において、TC平面培養とは、基板を
用いることなく、培養皿前面に均一に細胞を播種した比
較例を示し、TCパターニング培養が本実施例の場合を
示す。図から明らかなように、実施例の場合も、比較例
と同様に、約100時間ほどはアルブミン産生能を維持
していることがわかる。つまり、スリット状の貫通孔内
で細胞培養を行った場合でも、平面培養と同等のアルブ
ミン産生能を維持している。図5にシトクロムP450によ
るmRNA発現試験のデータを示す。なお測定はRT−
PCR法による。図から明らかなように、実施例の場合
も、比較例と同様に、約48時間ほどはmRNAを発現
している。上記から明らかなように、細胞の接着部位を
貫通孔内に制限しても、肝実質細胞の有する機能が損な
われない。そして、前記のように、一層目(第1の細
胞)を貫通孔内に培養、増殖させた後、2層目(第2の
細胞)以降の細胞を3次元構造の積層状態に培養するこ
とで、生体外であっても、生体内とほぼ同等の細胞の機
能を保持する細胞チップを製造することが可能となっ
た。
Example The cell culture apparatus shown in FIG. 2 was used. PSN (Penicillin, Streptomycin,
Neomycin: 10 vol% FB in 90 vol% of WE medium (Williams' Medium E) containing antibiotics)
A medium (culture solution) supplemented with S (Fetal bovine serum) was supplied in such an amount that the substrate 10 was immersed, and hepatocytes isolated from the mouse were suspended (sown) in the medium. Furthermore, EGF 10ng / ml (Epidermal growth
factor: epidermal growth factor), insulin 1μ
g / ml was added to promote the proliferation of hepatocytes. 1 cell
Using 1 ml of medium per well, 150,000 cells were seeded. After seeding, RNA in the medium and cells was periodically collected, and albumin producing ability and cytochrome P450 mRNA expression were measured. Fig. 4 shows albumin production ability. In the figure, TC plane culture refers to a comparative example in which cells are uniformly seeded on the front surface of a culture dish without using a substrate, and TC patterning culture is the case of this example. As is clear from the figure, also in the case of the example, it can be seen that the albumin producing ability is maintained for about 100 hours as in the comparative example. That is, even when the cell culture is performed in the slit-shaped through-hole, the albumin production ability equivalent to that in the flat culture is maintained. FIG. 5 shows data of mRNA expression test using cytochrome P450. The measurement is RT-
By PCR method. As is clear from the figure, also in the case of Example, mRNA was expressed for about 48 hours as in Comparative Example. As is clear from the above, the function of liver parenchymal cells is not impaired even if the cell adhesion site is restricted to the through hole. Then, as described above, after culturing and proliferating the first layer (first cells) in the through-holes, culturing the cells in the second layer (second cells) and subsequent layers in a three-dimensional laminated state Thus, it has become possible to manufacture a cell chip that retains almost the same cell function as that in vivo, even in vitro.

【0015】[0015]

【発明の効果】以上のように、本発明に係る細胞培養用
基板および細胞培養方法によれば、異種細胞が、3次元
構造の積層状態に培養、増殖することで、生体外であっ
ても、生体内とほぼ同等の細胞の機能を保持する細胞チ
ップを製造することが可能となった。
As described above, according to the cell culture substrate and cell culture method of the present invention, heterogeneous cells can be cultured and propagated in a laminated state having a three-dimensional structure, so that they can be used in vitro. It has become possible to manufacture a cell chip that retains almost the same cell function as in vivo.

【図面の簡単な説明】[Brief description of drawings]

【図1】細胞培養用基板の説明図である。FIG. 1 is an explanatory diagram of a cell culture substrate.

【図2】細胞培養用装置の説明図である。FIG. 2 is an explanatory diagram of a cell culture device.

【図3】培養が完了した状態の模式図である。FIG. 3 is a schematic diagram showing a state where the culture is completed.

【図4】アルブミン産生能を示すグラフである。FIG. 4 is a graph showing albumin production ability.

【図5】シトクロムP450によるmRNA発現試験の
データを示すグラフである。
FIG. 5 is a graph showing data of an mRNA expression test using cytochrome P450.

【符号の説明】[Explanation of symbols]

10 基板 12 貫通孔 14 培養皿 16 第1の細胞 18 第2の細胞 10 substrates 12 through holes 14 culture dish 16 First cell 18 second cell

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 培養すべき細胞が接着しない、非細胞接
着性の材料からなる細胞培養用基板であって、内部で、
異なる細胞が基板の厚み方向に積層状態で培養されるス
リット状の貫通孔を有することを特徴とする細胞培養用
基板。
1. A cell culture substrate made of a non-cell-adhesive material to which cells to be cultured do not adhere, wherein:
A cell culture substrate having slit-shaped through holes for culturing different cells in a stacked state in the thickness direction of the substrate.
【請求項2】 非接着性の材料がシリコンゴムもしくは
アガロースゲルからなることを特徴とする請求項1記載
の細胞培養用基板。
2. The cell culture substrate according to claim 1, wherein the non-adhesive material is silicon rubber or agarose gel.
【請求項3】 請求項1または2記載の細胞培養用基板
が、細胞接着性の材料からなる培養皿上に密着されてい
ることを特徴とする細胞培養用装置。
3. An apparatus for cell culture, wherein the cell culture substrate according to claim 1 or 2 is in close contact with a culture dish made of a cell adhesive material.
【請求項4】 請求項3記載の細胞培養用装置に培養液
を供給し、前記基板上に多数の第1の細胞を播種し、所
要温度条件に維持して、播種された細胞を前記貫通孔内
で前記培養皿に接着した状態で培養する工程と、 前記貫通孔内で培養された第1の細胞上に第2の細胞を
培養する工程とを具備することを特徴とする細胞培養方
法。
4. A culture solution is supplied to the cell culture device according to claim 3, a large number of first cells are seeded on the substrate, and the seeded cells are penetrated by maintaining the temperature conditions as required. A method of culturing cells, comprising a step of culturing while adhering to the culture dish in the holes, and a step of culturing second cells on the first cells cultured in the through holes. .
JP2002055510A 2002-03-01 2002-03-01 Substrate for cell culture and method for cell culture Pending JP2003250517A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002055510A JP2003250517A (en) 2002-03-01 2002-03-01 Substrate for cell culture and method for cell culture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002055510A JP2003250517A (en) 2002-03-01 2002-03-01 Substrate for cell culture and method for cell culture

Publications (1)

Publication Number Publication Date
JP2003250517A true JP2003250517A (en) 2003-09-09

Family

ID=28666326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002055510A Pending JP2003250517A (en) 2002-03-01 2002-03-01 Substrate for cell culture and method for cell culture

Country Status (1)

Country Link
JP (1) JP2003250517A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006115723A (en) * 2004-10-20 2006-05-11 Onchip Cellomics Consortium Microchamber for cell culture and method for constructing cellular structure
JP2007024576A (en) * 2005-07-13 2007-02-01 Fujifilm Holdings Corp Toxicity testing apparatus for cellular multi-layer culture
JP2019110871A (en) * 2017-12-26 2019-07-11 東洋合成工業株式会社 Cell culture plate and cell complex

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006115723A (en) * 2004-10-20 2006-05-11 Onchip Cellomics Consortium Microchamber for cell culture and method for constructing cellular structure
JP4664646B2 (en) * 2004-10-20 2011-04-06 一般社団法人オンチップ・セロミクス・コンソーシアム Cell culture microchamber and cell structure construction method
JP2007024576A (en) * 2005-07-13 2007-02-01 Fujifilm Holdings Corp Toxicity testing apparatus for cellular multi-layer culture
JP2019110871A (en) * 2017-12-26 2019-07-11 東洋合成工業株式会社 Cell culture plate and cell complex

Similar Documents

Publication Publication Date Title
JP4567936B2 (en) Support material for cell culture, cell co-culture method and co-culture cell sheet obtained therefrom
Kim et al. Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure
Anada et al. An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids
EP1939280B1 (en) Cultured cell construct which contains spheroids of cultured animal cells and the use thereof
Nishizawa et al. Micropatterning of HeLa cells on glass substrates and evaluation of respiratory activity using microelectrodes
Fukuda et al. Orderly arrangement of hepatocyte spheroids on a microfabricated chip
JP5583312B2 (en) Tissue formation substrate, tissue formation kit, tissue formation method using the same, and three-dimensional tissue formed by the tissue formation method
US9206391B2 (en) Method for preparing biological tissue
WO2002092778A2 (en) Device and method for three-dimensional spatial localization and functional interconnection of different types of cells
CN109790515B (en) Method for producing cellular tissue and porous membrane
CN102382765B (en) Device for patterning cocultivation of multiple cells, preparation method and use thereof
JP2015211688A (en) Method for inducing differentiation of embryonic stem cell or artificial pluripotent stem cell
Shimizu et al. Micropatterning of single myotubes on a thermoresponsive culture surface using elastic stencil membranes for single-cell analysis
Di Nardo et al. Engineering the stem cell niche and the differentiative micro-and macroenvironment: technologies and tools for applying biochemical, physical and structural stimuli and their effects on stem cells
JP2003250517A (en) Substrate for cell culture and method for cell culture
WO2013005780A1 (en) Matrix for recovering cell fragments for therapeutic use and method for producing cell fragments for therapeutic use using same, and matrix for recovering cell fragments for subculture and method for producing cell fragments for subculture using same
JP6678520B2 (en) Method for producing cell aggregate
JP6364734B2 (en) Cell sheet production method and transport method
US10160954B2 (en) Engineered physical alignment of stem cell-derived cardiomyocytes
Guan et al. Macromolecular crowding facilitates rapid fabrication of intact, robust cell sheets
JP6248617B2 (en) Cell sheet manufacturing method
Khait et al. Variable optimization for the formation of three-dimensional self-organized heart muscle
WO2023149068A1 (en) Cell culture method and masking sheet
Patel Engineering 2D and 3D Human Skeletal Muscle Models
KR20220033735A (en) Multi layer cell sheet including multi cell and the method for manufacturing thereof